Monitor subsequent quarterly filings for any revenue contribution from Remexian's German operations or expansion of pharmacy network. No immediate trading catalyst — this filing does not change fundamentals or valuation.
Price Chart
Executive Summary
High Tide's German subsidiary Remexian Pharma showcased exclusive Canadian medical cannabis brand distribution partnerships at the Mary Jane Berlin 2026 trade show. The event highlighted Remexian's expanding portfolio of exclusive agreements with brands like Tribal, Highly Dutch Organic, and Weed Me, and its position as a leading importer/distributor in Germany's medical cannabis market. This is a routine business development update with no financial figures or material changes disclosed.
Key Facts
- Remexian showcased exclusive Canadian medical cannabis brand partnerships at Mary Jane Berlin 2026, held June 11-14 in Berlin, Germany
- Brands featured include Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals and Castle Rock Farms
- Remexian holds a 14% share of the German medical cannabis market and is licensed to import from 19 countries
- No revenue, earnings, margin, deal value, or guidance figures were provided in the filing
Financial Impact
No financial figures disclosed; filing is a routine operational update
Risk Factors
- Forward-looking statements regarding market share capture are speculative and unquantified
- German medical cannabis regulatory changes could impact Remexian's distribution advantage
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000566 |
| Exhibit: ex991.htm | 0001279569-26-000566 |
| Document: 0001279569-26-000566-index-headers.html | 0001279569-26-000566 |
| Document: 0001279569-26-000566-index.html | 0001279569-26-000566 |
| Document: 0001279569-26-000566.txt | 0001279569-26-000566 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 6-K | $2.61 $2.57 | ▼ −1.53% | ▲ +0.44% | $2.67 (+2.30%) |
Oct 1, 2026 26d ago | 6-K | $2.67 $2.58 | ▼ −3.37% | ▼ −4.67% | $2.67 (+0.00%) |
Sep 28, 2026 29d ago | 6-K | $2.81 $2.73 | ▼ −2.85% | ▼ −4.05% | $2.67 (−4.98%) |
Sep 28, 2026 29d ago | Press Release | $2.81 $2.73 | ▲ +2.85% | ▲ +4.05% | $2.67 (+4.98%) |
Sep 23, 2026 4w ago | 6-K | $2.72 $2.73 | ▲ +0.37% | ▲ +1.04% | $2.67 (−1.84%) |
Sep 14, 2026 6w ago | 6-K | $2.63 $2.63 | · 0.00% | ▼ −0.11% | $2.67 (+1.52%) |
Aug 31, 2026 8w ago | 6-K | $2.51 $2.69 | ▲ +7.17% | ▲ +7.31% | $2.67 (+6.37%) |
Aug 25, 2026 9w ago | 6-K | $2.57 $2.48 | ▼ −3.50% | ▼ −2.96% | $2.67 (+3.89%) |
Aug 25, 2026 9w ago | Press Release | $2.57 $2.48 | ▼ −3.50% | ▼ −2.96% | $2.67 (+3.89%) |
Aug 12, 2026 10w ago | 6-K | $2.33 $2.46 | ▲ +5.58% | ▲ +6.02% | $2.67 (+14.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers